Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2004 3
2005 1
2006 2
2007 1
2008 2
2009 3
2010 2
2012 2
2013 3
2014 2
2015 6
2016 4
2017 8
2018 17
2019 19
2020 14
2021 10
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 34410944

87 results
Results by year
Filters applied: . Clear all
Page 1
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC.
La Monica S, Minari R, Cretella D, Flammini L, Fumarola C, Bonelli M, Cavazzoni A, Digiacomo G, Galetti M, Madeddu D, Falco A, Lagrasta CA, Squadrilli A, Barocelli E, Romanel A, Quaini F, Petronini PG, Tiseo M, Alfieri R. La Monica S, et al. J Exp Clin Cancer Res. 2019 May 28;38(1):222. doi: 10.1186/s13046-019-1240-x. J Exp Clin Cancer Res. 2019. PMID: 31138260 Free PMC article.
87 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page